{"id":1115,"date":"2024-07-23T16:09:00","date_gmt":"2024-07-23T15:09:00","guid":{"rendered":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/?page_id=1115"},"modified":"2024-07-23T16:14:41","modified_gmt":"2024-07-23T15:14:41","slug":"marian-montanha","status":"publish","type":"page","link":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/marian-montanha\/","title":{"rendered":"Marian Montanha"},"content":{"rendered":"\n<p>Clinical Studies Officer<\/p>\n\n\n<div class=\"gb-container gb-container-8b41894d\">\n<div class=\"wp-block-image is-resized\">\n<figure class=\"alignleft size-medium\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-content\/uploads\/sites\/111\/2024\/06\/Marian-Profile-300x300.jpg\" alt=\"\" class=\"wp-image-1117\" style=\"width:235px;height:auto\" srcset=\"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-content\/uploads\/sites\/111\/2024\/06\/Marian-Profile-300x300.jpg 300w, https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-content\/uploads\/sites\/111\/2024\/06\/Marian-Profile-150x150.jpg 150w, https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-content\/uploads\/sites\/111\/2024\/06\/Marian-Profile-768x767.jpg 768w, https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-content\/uploads\/sites\/111\/2024\/06\/Marian-Profile.jpg 961w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><figcaption class=\"wp-element-caption\">BSc, MSc<\/figcaption><\/figure>\n<\/div>\n\n\n<h4 class=\"wp-block-heading\">Biography<\/h4>\n\n\n\n<p>I joined the Neuroprogressive and Dementia Network in June 2024. Prior to this I was involved in research focusing on early detection methods for Alzheimer&#8217;s disease which explored digital cognitive assessment tools, and blood-based biomarker tests for the Apolipoprotein E proteotype and measurement of Beta Amyloid protein ratios. Additionally, I worked as an assistant psychologist for Older Adults, supporting dementia diagnostic investigations. I am passionate about improving patient care and advancing research into neuroprogressive disorders and dementia<\/p>\n\n<\/div>\n\n\n<div class=\"wp-block-group has-light-accent-grey-background-color has-background\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<h2 class=\"wp-block-heading has-text-align-left colourtextbold\">Contact <\/h2>\n\n\n\n<p class=\"has-text-align-left\"><br>Email: <a href=\"mailto:marian.montanha2@nhs.scot\" target=\"_blank\" rel=\"noreferrer noopener\">Marian.montanha2@nhs.scot<\/a><br><br>NDN Tel: <a href=\"tel:01315373804\">0131 537 3804<\/a><\/p>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Clinical Studies Officer Biography I joined the Neuroprogressive and Dementia Network in June 2024. Prior to this I was involved in research focusing on early detection methods for Alzheimer&rsquo;s disease which explored digital cognitive assessment tools, and blood-based biomarker tests for the Apolipoprotein E proteotype and measurement of Beta Amyloid protein ratios. Additionally, I worked<\/p>\n","protected":false},"author":198,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[17],"class_list":["post-1115","page","type-page","status-publish","hentry","category-ndn-staff"],"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"connordalby","author_link":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/author\/connordalby\/"},"rttpg_comment":0,"rttpg_category":" <a href=\"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/category\/ndn-staff\/\" rel=\"tag\">NDN Staff<\/a>","rttpg_excerpt":"Clinical Studies Officer Biography I joined the Neuroprogressive and Dementia Network in June 2024. Prior to this I was involved in research focusing on early detection methods for Alzheimer&rsquo;s disease which explored digital cognitive assessment tools, and blood-based biomarker tests for the Apolipoprotein E proteotype and measurement of Beta Amyloid protein ratios. Additionally, I worked","_links":{"self":[{"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/pages\/1115","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/users\/198"}],"replies":[{"embeddable":true,"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/comments?post=1115"}],"version-history":[{"count":3,"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/pages\/1115\/revisions"}],"predecessor-version":[{"id":1508,"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/pages\/1115\/revisions\/1508"}],"wp:attachment":[{"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/media?parent=1115"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/wp-json\/wp\/v2\/categories?post=1115"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}